{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:26:54Z","timestamp":1792506414975,"version":"4.5.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T00:00:00Z","timestamp":1731024000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T00:00:00Z","timestamp":1731024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biomed"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Endometrial cancer (EC) rates are continuing to rise and\u00a0it remains the most common gynecologic cancer in the US. Existing\u00a0diagnostic methods are invasive and can cause pain and anxiety. Hence, there is a need for less invasive diagnostics for early EC detection. The study objective was to evaluate the utility of growth factors collected through minimally invasive cervicovaginal lavage (CVL) sampling as diagnostic and prognostic biomarkers for EC. CVL samples from 192 individuals undergoing hysterectomy for benign or malignant conditions were collected and used to quantify the concentrations of 19 growth and angiogenic factors using multiplex immunoassays. Patients\u00a0were categorized\u00a0based on disease groups: benign conditions (<jats:italic>n<\/jats:italic>\u2009=\u2009108), endometrial hyperplasia (<jats:italic>n<\/jats:italic>\u2009=\u200918), and EC (<jats:italic>n<\/jats:italic>\u2009=\u200966). EC group was stratified into grade 1\/2 endometrial endometrioid cancer (<jats:italic>n<\/jats:italic>\u2009=\u200953) and other EC subtypes (<jats:italic>n<\/jats:italic>\u2009=\u200913). Statistical associations were assessed using receiver operating characteristics, Spearman correlations and hierarchical clustering. Growth and angiogenic factors: angiopoietin-2, endoglin, fibroblast activation protein (FAP), melanoma inhibitory activity, and vascular endothelial growth factor-A (VEGF-A) were significantly (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001) elevated in EC patients. A multivariate model combining 11 proteins with patient age and body mass index exhibited excellent discriminatory potential (area under curve\u2009=\u20090.918) for EC, with a specificity of 90.7% and a sensitivity of 87.8%. Moreover, angiopoietin-2, FAP and VEGF-A significantly (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05\u20130.001) associated with tumor grade, size, myometrial invasion, and mismatch repair status. Our results highlight the innovative use of growth and angiogenic factors collected through CVL sampling for the detecting endometrial cancer, showcasing not only their diagnostic potential but also their prognostic value.\n<\/jats:p>","DOI":"10.1186\/s43556-024-00219-6","type":"journal-article","created":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T00:01:58Z","timestamp":1731024118000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Cervicovaginal lavages uncover growth factors as key biomarkers for early diagnosis and prognosis of endometrial cancer"],"prefix":"10.1186","volume":"5","author":[{"given":"Hannah J.","family":"Harris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawe\u0142","family":"\u0141aniewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise J.","family":"Roe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana M.","family":"Chase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa M.","family":"Herbst-Kralovetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,8]]},"reference":[{"issue":"1","key":"219_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349. https:\/\/doi.org\/10.3322\/caac.21820.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"219_CR2","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ajog.2020.07.001","volume":"223","author":"ED Paskett","year":"2020","unstructured":"Paskett ED, Bernardo BM. Eliminating disparities in endometrial cancer: adherence to high-quality care is not enough. Am J Obstet Gynecol. 2020;223(3):309\u201311. https:\/\/doi.org\/10.1016\/j.ajog.2020.07.001.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"219_CR3","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.ygyno.2014.10.021","volume":"135","author":"AM Rodriguez","year":"2014","unstructured":"Rodriguez AM, Schmeler KM, Kuo YF. Disparities in endometrial cancer outcomes between non-Hispanic White and Hispanic women. Gynecol Oncol. 2014;135(3):525\u201333. https:\/\/doi.org\/10.1016\/j.ygyno.2014.10.021.","journal-title":"Gynecol Oncol"},{"key":"219_CR4","first-page":"e1","volume":"3","author":"K Batai","year":"2019","unstructured":"Batai K, Gachupin FC, Estrada AL, Garcia DO, Gomez J, Kittles RA. Patterns of cancer related health disparities in Arizona. Cancer Health Disparities. 2019;3:e1\u201320.","journal-title":"Cancer Health Disparities"},{"issue":"6","key":"219_CR5","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.ajog.2020.12.1213","volume":"224","author":"K Matsuo","year":"2021","unstructured":"Matsuo K, Mandelbaum RS, Matsuzaki S, Klar M, Roman LD, Wright JD. Ovarian conservation for young women with early-stage, low-grade endometrial cancer: a 2-step schema. Am J Obstet Gynecol. 2021;224(6):574\u201384. https:\/\/doi.org\/10.1016\/j.ajog.2020.12.1213.","journal-title":"Am J Obstet Gynecol"},{"issue":"10333","key":"219_CR6","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1016\/S0140-6736(22)00323-3","volume":"399","author":"EJ Crosbie","year":"2022","unstructured":"Crosbie EJ, Kitson SJ, McAlpine JN, Mukhopadhyay A, Powell ME, Singh N. Endometrial cancer. Lancet. 2022;399(10333):1412\u201328. https:\/\/doi.org\/10.1016\/S0140-6736(22)00323-3.","journal-title":"Lancet"},{"issue":"1","key":"219_CR7","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41572-021-00324-8","volume":"7","author":"V Makker","year":"2021","unstructured":"Makker V, MacKay H, Ray-Coquard I, Levine DA, Westin SN, Aoki D, Oaknin A. Endometrial cancer. Nat Rev Dis Primers. 2021;7(1):88. https:\/\/doi.org\/10.1038\/s41572-021-00324-8.","journal-title":"Nat Rev Dis Primers"},{"issue":"7447","key":"219_CR8","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nature12113","volume":"497","author":"DA Levine","year":"2013","unstructured":"Levine DA, Getz G, Gabriel SB, Cibulskis K, Lander E, Sivachenko A, et al. Integrated genomic characterization of endometrial carcinoma. Nature. 2013;497(7447):67\u201373. https:\/\/doi.org\/10.1038\/nature12113.","journal-title":"Nature"},{"issue":"Iss 1 Suppl 1","key":"219_CR9","doi-asserted-by":"publisher","first-page":"S93","DOI":"10.1097\/PGP.0000000000000524","volume":"38","author":"N Singh","year":"2019","unstructured":"Singh N, Hirschowitz L, Zaino R, Alvarado-Cabrero I, Duggan MA, Ali-Fehmi R, et al. Pathologic prognostic factors in endometrial carcinoma (other than tumor type and grade). Int J Gynecol Pathol. 2019;38(Iss 1 Suppl 1):S93\u2013s113. https:\/\/doi.org\/10.1097\/PGP.0000000000000524.","journal-title":"Int J Gynecol Pathol"},{"issue":"8 Suppl","key":"219_CR10","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1002\/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO;2-8","volume":"60","author":"WT Creasman","year":"1987","unstructured":"Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer. A gynecologic oncology group study. Cancer. 1987;60(8 Suppl):2035\u201341.","journal-title":"Cancer"},{"key":"219_CR11","doi-asserted-by":"publisher","first-page":"762329","DOI":"10.3389\/fonc.2021.762329","volume":"11","author":"J Wang","year":"2021","unstructured":"Wang J, Xu P, Yang X, Yu Q, Xu X, Zou G, Zhang X. Association of myometrial invasion with lymphovascular space invasion, lymph node metastasis, recurrence, and overall survival in endometrial cancer: a meta-analysis of 79 studies with 68,870 patients. Front Oncol. 2021;11:762329. https:\/\/doi.org\/10.3389\/fonc.2021.762329.","journal-title":"Front Oncol"},{"key":"219_CR12","doi-asserted-by":"publisher","unstructured":"Jin X, Shen C, Yang X, Yu Y, Wang J, Che X. Association of tumor size with myometrial invasion, lymphovascular space invasion, lymph node metastasis, and recurrence in endometrial cancer: a meta-analysis of 40 studies with 53,276 patients. Front Oncol. 2022;12:881850. https:\/\/doi.org\/10.3389\/fonc.2022.881850.","DOI":"10.3389\/fonc.2022.881850"},{"issue":"7\u20138","key":"219_CR13","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1159\/000488112","volume":"41","author":"K G\u00fcng\u00f6rd\u00fck","year":"2018","unstructured":"G\u00fcng\u00f6rd\u00fck K, Firat C\u00fcylan Z, Kahramanoglu I, Oge T, Akbayir O, Dede M, et al. Risk factors for recurrence in low-risk endometrial cancer: a case-control study. Oncol Res Treat. 2018;41(7\u20138):466\u201370. https:\/\/doi.org\/10.1159\/000488112.","journal-title":"Oncol Res Treat"},{"issue":"6","key":"219_CR14","first-page":"455","volume":"49","author":"M Li","year":"2014","unstructured":"Li M, Wang Z, Zhao L, Li X, Wang J, Zhang C, Wei L. Predictors of recurrence and prognosis in patients with stage I and II endometrial carcinoma. Zhonghua Fu Chan Ke Za Zhi. 2014;49(6):455\u20139.","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"issue":"13","key":"219_CR15","doi-asserted-by":"publisher","first-page":"4239","DOI":"10.1245\/s10434-014-3864-6","volume":"21","author":"S Bendifallah","year":"2014","unstructured":"Bendifallah S, Canlorbe G, Huguet F, Coutant C, Hudry D, Graesslin O, et al. A risk scoring system to determine recurrence in early-stage type 1 endometrial cancer: a French multicentre study. Ann Surg Oncol. 2014;21(13):4239\u201345. https:\/\/doi.org\/10.1245\/s10434-014-3864-6.","journal-title":"Ann Surg Oncol"},{"key":"219_CR16","doi-asserted-by":"publisher","unstructured":"Practice Bulletin No. 149: Endometrial Cancer. Obstet Gynecol. 2015;125(4):1006\u201326. https:\/\/doi.org\/10.1097\/01.AOG.0000462977.61229.de.","DOI":"10.1097\/01.AOG.0000462977.61229.de"},{"issue":"2","key":"219_CR17","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.mcna.2022.10.014","volume":"107","author":"E Lebduska","year":"2023","unstructured":"Lebduska E, Beshear D, Spataro BM. Abnormal uterine bleeding. Med Clin North Am. 2023;107(2):235\u201346. https:\/\/doi.org\/10.1016\/j.mcna.2022.10.014.","journal-title":"Med Clin North Am"},{"issue":"3","key":"219_CR18","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10397-015-0895-3","volume":"12","author":"P Gambadauro","year":"2015","unstructured":"Gambadauro P, Navaratnarajah R, Carli V. Anxiety at outpatient hysteroscopy. Gynecol Surg. 2015;12(3):189\u201396. https:\/\/doi.org\/10.1007\/s10397-015-0895-3.","journal-title":"Gynecol Surg"},{"issue":"6","key":"219_CR19","first-page":"468","volume":"93","author":"MM Braun","year":"2016","unstructured":"Braun MM, Overbeek-Wager EA, Grumbo RJ. Diagnosis and management of endometrial cancer. Am Fam Physician. 2016;93(6):468\u201374.","journal-title":"Am Fam Physician"},{"issue":"3","key":"219_CR20","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.ygyno.2020.01.032","volume":"157","author":"B Long","year":"2020","unstructured":"Long B, Clarke MA, Morillo ADM, Wentzensen N, Bakkum-Gamez JN. Ultrasound detection of endometrial cancer in women with postmenopausal bleeding: systematic review and meta-analysis. Gynecol Oncol. 2020;157(3):624\u201333. https:\/\/doi.org\/10.1016\/j.ygyno.2020.01.032.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"219_CR21","doi-asserted-by":"publisher","first-page":"192","DOI":"10.5468\/ogs.2016.59.3.192","volume":"59","author":"MJ Kim","year":"2016","unstructured":"Kim MJ, Kim JJ, Kim SM. Endometrial evaluation with transvaginal ultrasonography for the screening of endometrial hyperplasia or cancer in premenopausal and perimenopausal women. Obstet Gynecol Sci. 2016;59(3):192\u2013200. https:\/\/doi.org\/10.5468\/ogs.2016.59.3.192.","journal-title":"Obstet Gynecol Sci"},{"issue":"8","key":"219_CR22","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1001\/jamaoncol.2021.1700","volume":"7","author":"KM Doll","year":"2021","unstructured":"Doll KM, Romano SS, Marsh EE, Robinson WR. Estimated Performance of transvaginal ultrasonography for evaluation of postmenopausal bleeding in a simulated cohort of black and white women in the US. JAMA Oncol. 2021;7(8):1158\u201365. https:\/\/doi.org\/10.1001\/jamaoncol.2021.1700.","journal-title":"JAMA Oncol"},{"issue":"3","key":"219_CR23","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1097\/01.AOG.0000136080.55874.7f","volume":"104","author":"LC van Doorn","year":"2004","unstructured":"van Doorn LC, Dijkhuizen FP, Kruitwagen RF, Heintz AP, Kooi GS, Mol BW. Accuracy of transvaginal ultrasonography in diabetic or obese women with postmenopausal bleeding. Obstet Gynecol. 2004;104(3):571\u20138. https:\/\/doi.org\/10.1097\/01.AOG.0000136080.55874.7f.","journal-title":"Obstet Gynecol"},{"key":"219_CR24","doi-asserted-by":"publisher","first-page":"63S","DOI":"10.1097\/01.AOG.0000665100.70110.e3","volume":"135","author":"S Adambekov","year":"2020","unstructured":"Adambekov S, Lopa S, Edwards RP, Bovbjerg DH, Linkov F, Donnellan N. Anxiety and pain in patients undergoing Pipelle endometrial biopsy: a prospective study [11F]. Obstet Gynecol. 2020;135:63S. https:\/\/doi.org\/10.1097\/01.AOG.0000665100.70110.e3.","journal-title":"Obstet Gynecol"},{"issue":"2","key":"219_CR25","first-page":"145","volume":"26","author":"R Rauf","year":"2014","unstructured":"Rauf R, Shaheen A, Sadia S, Waqar F, Zafar S, Sultana S, Waseem S. Outpatient endometrial biopsy with Pipelle vs diagnostic dilatation and curettage. J Ayub Med Coll Abbottabad. 2014;26(2):145\u20138.","journal-title":"J Ayub Med Coll Abbottabad"},{"issue":"1","key":"219_CR26","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/1477-7819-12-169","volume":"12","author":"Y Bie","year":"2014","unstructured":"Bie Y, Zhang Z. Diagnostic value of serum HE4 in endometrial cancer: a meta-analysis. World J Surg Oncol. 2014;12(1):169. https:\/\/doi.org\/10.1186\/1477-7819-12-169.","journal-title":"World J Surg Oncol."},{"key":"219_CR27","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cca.2018.11.011","volume":"488","author":"J Li","year":"2019","unstructured":"Li J, Wang X, Qu W, Wang J, Jiang S-W. Comparison of serum human epididymis protein 4 and CA125 on endometrial cancer detection: a meta-analysis. Clin Chim Acta. 2019;488:215\u201320. https:\/\/doi.org\/10.1016\/j.cca.2018.11.011.","journal-title":"Clin Chim Acta"},{"issue":"1","key":"219_CR28","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12943-023-01757-3","volume":"22","author":"Y Shen","year":"2023","unstructured":"Shen Y, Yang W, Liu J, Zhang Y. Minimally invasive approaches for the early detection of endometrial cancer. Mol Cancer. 2023;22(1):53. https:\/\/doi.org\/10.1186\/s12943-023-01757-3.","journal-title":"Mol Cancer"},{"issue":"1","key":"219_CR29","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s40364-022-00438-5","volume":"10","author":"P \u0141aniewski","year":"2022","unstructured":"\u0141aniewski P, Cui H, Mahnert ND, Mourad J, Borst MP, Willmott L, et al. Protein biomarkers in cervicovaginal lavages for detection of endometrial cancer. Biomarker Research. 2022;10(1):88. https:\/\/doi.org\/10.1186\/s40364-022-00438-5.","journal-title":"Biomarker Research."},{"issue":"12","key":"219_CR30","doi-asserted-by":"publisher","first-page":"3194","DOI":"10.1002\/ijc.32514","volume":"145","author":"L Costas","year":"2019","unstructured":"Costas L, Frias-Gomez J, Guardiola M, Benavente Y, Pineda M, Pav\u00f3n M\u00c1, et al. New perspectives on screening and early detection of endometrial cancer. Int J Cancer. 2019;145(12):3194\u2013206. https:\/\/doi.org\/10.1002\/ijc.32514.","journal-title":"Int J Cancer"},{"issue":"1","key":"219_CR31","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ygyno.2010.11.028","volume":"121","author":"I Benjamin","year":"2011","unstructured":"Benjamin I, Dalton H, Qiu Y, Cayco L, Johnson WG, Balducci J. Endometrial cancer surgery in Arizona: a statewide analysis of access to care. Gynecol Oncol. 2011;121(1):83\u20136. https:\/\/doi.org\/10.1016\/j.ygyno.2010.11.028.","journal-title":"Gynecol Oncol"},{"key":"219_CR32","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ygyno.2024.01.010","volume":"182","author":"AJ Fife","year":"2024","unstructured":"Fife AJ, Najor AJ, Aspir TB, Haines KE, Vilardo NA, Isani SS, et al. Reduced healthcare access contributes to delay of care in endometrial cancer. Gynecol Oncol. 2024;182:115\u201320. https:\/\/doi.org\/10.1016\/j.ygyno.2024.01.010.","journal-title":"Gynecol Oncol"},{"key":"219_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ygyno.2024.03.015","volume":"186","author":"N Desravines","year":"2024","unstructured":"Desravines N, Hazimeh D, Desjardins MR, Wethington SL. Healthcare utilization in women diagnosed with endometrial cancer: a survey-based study. Gynecol Oncol. 2024;186:1\u20138. https:\/\/doi.org\/10.1016\/j.ygyno.2024.03.015.","journal-title":"Gynecol Oncol"},{"key":"219_CR34","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cca.2018.03.040","volume":"482","author":"LM Li","year":"2018","unstructured":"Li LM, Zhu YX, Zhong Y, Su T, Fan XM, Xi Q, et al. Human epididymis protein 4 in endometrial cancer: a meta-analysis. Clin Chim Acta. 2018;482:215\u201323. https:\/\/doi.org\/10.1016\/j.cca.2018.03.040.","journal-title":"Clin Chim Acta"},{"issue":"3","key":"219_CR35","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1179\/174313405X40323","volume":"13","author":"M Russell","year":"2005","unstructured":"Russell M. Does patient ethnicity or sonographer gender have any bearing on patient acceptability of transvaginal ultrasound? Ultrasound. 2005;13(3):170\u20132. https:\/\/doi.org\/10.1179\/174313405X40323.","journal-title":"Ultrasound"},{"issue":"2","key":"219_CR36","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1046\/j.1469-0705.1997.09020091.x","volume":"9","author":"JM Braithwaite","year":"1997","unstructured":"Braithwaite JM, Economides DL. Acceptability by patients of transvaginal sonography in the elective assessment of the first-trimester fetus. Ultrasound Obstet Gynecol. 1997;9(2):91\u20133. https:\/\/doi.org\/10.1046\/j.1469-0705.1997.09020091.x.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"2","key":"219_CR37","doi-asserted-by":"publisher","first-page":"133","DOI":"10.12809\/hkmj208792","volume":"28","author":"LWY Fung","year":"2022","unstructured":"Fung LWY, Cheung ECW, Wong ASW, Sahota DS, Lao TTH. Patient acceptance of transvaginal sonographic endometrial thickness assessment compared with hysteroscopy and biopsy for exclusion of endometrial cancer in cases of postmenopausal bleeding. Hong Kong Med J. 2022;28(2):133\u20139. https:\/\/doi.org\/10.12809\/hkmj208792.","journal-title":"Hong Kong Med J"},{"issue":"1","key":"219_CR38","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/S1470-2045(10)70268-0","volume":"12","author":"I Jacobs","year":"2011","unstructured":"Jacobs I, Gentry-Maharaj A, Burnell M, Manchanda R, Singh N, Sharma A, et al. Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohort. Lancet Oncol. 2011;12(1):38\u201348. https:\/\/doi.org\/10.1016\/S1470-2045(10)70268-0.","journal-title":"Lancet Oncol"},{"issue":"12","key":"219_CR39","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1055\/s-0032-1328070","volume":"72","author":"E Steiner","year":"2012","unstructured":"Steiner E, Juhasz-B\u00f6sz I, Emons G, K\u00f6lbl H, Kimmig R, Mallmann P. Transvaginal ultrasound for endometrial carcinoma screening - current evidence-based data. Geburtshilfe Frauenheilkd. 2012;72(12):1088\u201391. https:\/\/doi.org\/10.1055\/s-0032-1328070.","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"5","key":"219_CR40","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1034\/j.1600-0412.1999.780519.x","volume":"78","author":"SH Bakour","year":"1999","unstructured":"Bakour SH, Dwarakanath LS, Khan KS, Newton JR, Gupta JK. The diagnostic accuracy of ultrasound scan in predicting endometrial hyperplasia and cancer in postmenopausal bleeding. Acta Obstet Gynecol Scand. 1999;78(5):447\u201351. https:\/\/doi.org\/10.1034\/j.1600-0412.1999.780519.x.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"11","key":"219_CR41","doi-asserted-by":"publisher","first-page":"4150","DOI":"10.1182\/blood-2003-10-3685","volume":"103","author":"U Fiedler","year":"2004","unstructured":"Fiedler U, Scharpfenecker M, Koidl S, Hegen A, Grunow V, Schmidt JM, et al. The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies. Blood. 2004;103(11):4150\u20136. https:\/\/doi.org\/10.1182\/blood-2003-10-3685.","journal-title":"Blood"},{"issue":"1","key":"219_CR42","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1074\/jbc.M113.506899","volume":"289","author":"R Ju","year":"2014","unstructured":"Ju R, Zhuang ZW, Zhang J, Lanahan AA, Kyriakides T, Sessa WC, Simons M. Angiopoietin-2 secretion by endothelial cell exosomes: regulation by the phosphatidylinositol 3-kinase (PI3K)\/Akt\/endothelial nitric oxide synthase (eNOS) and syndecan-4\/syntenin pathways. J Biol Chem. 2014;289(1):510\u20139. https:\/\/doi.org\/10.1074\/jbc.M113.506899.","journal-title":"J Biol Chem"},{"issue":"1","key":"219_CR43","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12964-020-00535-8","volume":"18","author":"J-y Xie","year":"2020","unstructured":"Xie J-y, Wei J-x, Lv L-h, Han Q-f, Yang W-b, Li G-l, et al. Angiopoietin-2 induces angiogenesis via exosomes in human hepatocellular carcinoma. Cell Commun Signal. 2020;18(1):46. https:\/\/doi.org\/10.1186\/s12964-020-00535-8.","journal-title":"Cell Commun Signal"},{"issue":"4","key":"219_CR44","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1128\/mcb.12.4.1698-1707.1992","volume":"12","author":"J Partanen","year":"1992","unstructured":"Partanen J, Armstrong E, Makela TP, Korhonen J, Sandberg M, Renkonen R, et al. A novel endothelial cell surface receptor tyrosine kinase with extracellular epidermal growth factor homology domains. Mol Cell Biol. 1992;12(4):1698\u2013707. https:\/\/doi.org\/10.1128\/mcb.12.4.1698-1707.1992.","journal-title":"Mol Cell Biol"},{"issue":"2","key":"219_CR45","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s10456-009-9147-3","volume":"12","author":"M Thomas","year":"2009","unstructured":"Thomas M, Augustin HG. The role of the Angiopoietins in vascular morphogenesis. Angiogenesis. 2009;12(2):125\u201337. https:\/\/doi.org\/10.1007\/s10456-009-9147-3.","journal-title":"Angiogenesis"},{"issue":"3","key":"219_CR46","doi-asserted-by":"publisher","first-page":"L582","DOI":"10.1152\/ajplung.2001.281.3.L582","volume":"281","author":"K Abdulmalek","year":"2001","unstructured":"Abdulmalek K, Ashur F, Ezer N, Ye F, Magder S, Hussain SN. Differential expression of Tie-2 receptors and angiopoietins in response to in vivo hypoxia in rats. Am J Physiol Lung Cell Mol Physiol. 2001;281(3):L582\u201390. https:\/\/doi.org\/10.1152\/ajplung.2001.281.3.L582.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"219_CR47","doi-asserted-by":"publisher","first-page":"e29907","DOI":"10.1080\/23723556.2015.1024821","volume":"1","author":"F Morfoisse","year":"2014","unstructured":"Morfoisse F, Renaud E, Hantelys F, Prats AC, Garmy-Susini B. Role of hypoxia and vascular endothelial growth factors in lymphangiogenesis. Mol Cell Oncol. 2014;1(1):e29907. https:\/\/doi.org\/10.4161\/mco.29907.","journal-title":"Mol Cell Oncol"},{"issue":"9","key":"219_CR48","doi-asserted-by":"publisher","first-page":"4254","DOI":"10.1158\/0008-5472.CAN-06-4100","volume":"67","author":"Y Imanishi","year":"2007","unstructured":"Imanishi Y, Hu B, Jarzynka MJ, Guo P, Elishaev E, Bar-Joseph I, Cheng SY. Angiopoietin-2 stimulates breast cancer metastasis through the alpha(5)beta(1) integrin-mediated pathway. Cancer Res. 2007;67(9):4254\u201363. https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-4100.","journal-title":"Cancer Res"},{"issue":"5","key":"219_CR49","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/sj.bjc.6601194","volume":"89","author":"CM Holland","year":"2003","unstructured":"Holland CM, Day K, Evans A, Smith SK. Expression of the VEGF and angiopoietin genes in endometrial atypical hyperplasia and endometrial cancer. Br J Cancer. 2003;89(5):891\u20138. https:\/\/doi.org\/10.1038\/sj.bjc.6601194.","journal-title":"Br J Cancer"},{"issue":"9","key":"219_CR50","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.7150\/jca.56436","volume":"12","author":"J Ao","year":"2021","unstructured":"Ao J, Chiba T, Kanzaki H, Kanayama K, Shibata S, Kurosugi A, et al. Serum angiopoietin 2 acts as a diagnostic and prognostic biomarker in hepatocellular carcinoma. J Cancer. 2021;12(9):2694\u2013701. https:\/\/doi.org\/10.7150\/jca.56436.","journal-title":"J Cancer"},{"issue":"1","key":"219_CR51","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/sj.bjc.6606005","volume":"104","author":"E Volkova","year":"2011","unstructured":"Volkova E, Willis JA, Wells JE, Robinson BA, Dachs GU, Currie MJ. Association of angiopoietin-2, C-reactive protein and markers of obesity and insulin resistance with survival outcome in colorectal cancer. Br J Cancer. 2011;104(1):51\u20139. https:\/\/doi.org\/10.1038\/sj.bjc.6606005.","journal-title":"Br J Cancer"},{"issue":"4","key":"219_CR52","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1158\/1078-0432.CCR-08-1615","volume":"15","author":"I Helfrich","year":"2009","unstructured":"Helfrich I, Edler L, Sucker A, Thomas M, Christian S, Schadendorf D, Augustin HG. Angiopoietin-2 levels are associated with disease progression in metastatic malignant melanoma. Clin Cancer Res. 2009;15(4):1384\u201392. https:\/\/doi.org\/10.1158\/1078-0432.CCR-08-1615.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"219_CR53","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1002\/ijc.32993","volume":"147","author":"M Jary","year":"2020","unstructured":"Jary M, Hasanova R, Vienot A, Asgarov K, Loyon R, Tirole C, et al. Molecular description of ANGPT2 associated colorectal carcinoma. Int J Cancer. 2020;147(7):2007\u201318. https:\/\/doi.org\/10.1002\/ijc.32993.","journal-title":"Int J Cancer"},{"issue":"1","key":"219_CR54","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1186\/s12885-020-07415-x","volume":"20","author":"KM Terlikowska","year":"2020","unstructured":"Terlikowska KM, Dobrzycka B, Terlikowski R, Sienkiewicz A, Kinalski M, Terlikowski SJ. Clinical value of selected markers of angiogenesis, inflammation, insulin resistance and obesity in type 1 endometrial cancer. BMC Cancer. 2020;20(1):921. https:\/\/doi.org\/10.1186\/s12885-020-07415-x.","journal-title":"BMC Cancer"},{"issue":"3","key":"219_CR55","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s10555-020-09909-3","volume":"39","author":"AA Fitzgerald","year":"2020","unstructured":"Fitzgerald AA, Weiner LM. The role of fibroblast activation protein in health and malignancy. Cancer Metastasis Rev. 2020;39(3):783\u2013803. https:\/\/doi.org\/10.1007\/s10555-020-09909-3.","journal-title":"Cancer Metastasis Rev"},{"issue":"1\u20132","key":"219_CR56","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.drup.2005.03.002","volume":"8","author":"T Kelly","year":"2005","unstructured":"Kelly T. Fibroblast activation protein-alpha and dipeptidyl peptidase IV (CD26): cell-surface proteases that activate cell signaling and are potential targets for cancer therapy. Drug Resist Updat. 2005;8(1\u20132):51\u20138. https:\/\/doi.org\/10.1016\/j.drup.2005.03.002.","journal-title":"Drug Resist Updat"},{"issue":"1","key":"219_CR57","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1089\/omi.2016.0159","volume":"21","author":"M Hu","year":"2017","unstructured":"Hu M, Qian C, Hu Z, Fei B, Zhou H. Biomarkers in tumor microenvironment? Upregulation of fibroblast activation protein-\u03b1 correlates with gastric cancer progression and poor prognosis. OMICS. 2017;21(1):38\u201344. https:\/\/doi.org\/10.1089\/omi.2016.0159.","journal-title":"OMICS"},{"issue":"6","key":"219_CR58","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1158\/1078-0432.CCR-06-1746","volume":"13","author":"LR Henry","year":"2007","unstructured":"Henry LR, Lee HO, Lee JS, Klein-Szanto A, Watts P, Ross EA, et al. Clinical implications of fibroblast activation protein in patients with colon cancer. Clin Cancer Res. 2007;13(6):1736\u201341. https:\/\/doi.org\/10.1158\/1078-0432.CCR-06-1746.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"219_CR59","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.molonc.2015.08.001","volume":"10","author":"MM Koczorowska","year":"2016","unstructured":"Koczorowska MM, Tholen S, Bucher F, Lutz L, Kizhakkedathu JN, De Wever O, et al. Fibroblast activation protein-\u03b1, a stromal cell surface protease, shapes key features of cancer associated fibroblasts through proteome and degradome alterations. Mol Oncol. 2016;10(1):40\u201358. https:\/\/doi.org\/10.1016\/j.molonc.2015.08.001.","journal-title":"Mol Oncol"},{"key":"219_CR60","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13045-015-0231-4","volume":"9","author":"F Teng","year":"2016","unstructured":"Teng F, Tian WY, Wang YM, Zhang YF, Guo F, Zhao J, et al. Cancer-associated fibroblasts promote the progression of endometrial cancer via the SDF-1\/CXCR4 axis. J Hematol Oncol. 2016;9:8. https:\/\/doi.org\/10.1186\/s13045-015-0231-4.","journal-title":"J Hematol Oncol"},{"issue":"7","key":"219_CR61","doi-asserted-by":"publisher","first-page":"e68923","DOI":"10.1371\/journal.pone.0068923","volume":"8","author":"KS Subramaniam","year":"2013","unstructured":"Subramaniam KS, Tham ST, Mohamed Z, Woo YL, Mat Adenan NA, Chung I. Cancer-associated fibroblasts promote proliferation of endometrial cancer cells. PLoS One. 2013;8(7):e68923. https:\/\/doi.org\/10.1371\/journal.pone.0068923.","journal-title":"PLoS One."},{"issue":"12","key":"219_CR62","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/j.ccell.2022.11.005","volume":"40","author":"Z Ma","year":"2022","unstructured":"Ma Z, Li X, Mao Y, Wei C, Huang Z, Li G, et al. Interferon-dependent SLC14A1+ cancer-associated fibroblasts promote cancer stemness via WNT5A in bladder cancer. Cancer Cell. 2022;40(12):1550-65.e7. https:\/\/doi.org\/10.1016\/j.ccell.2022.11.005.","journal-title":"Cancer Cell"},{"key":"219_CR63","doi-asserted-by":"publisher","first-page":"175586","DOI":"10.1016\/j.ejphar.2023.175586","volume":"949","author":"S Ghalehbandi","year":"2023","unstructured":"Ghalehbandi S, Yuzugulen J, Pranjol MZI, Pourgholami MH. The role of VEGF in cancer-induced angiogenesis and research progress of drugs targeting VEGF. Eur J Pharmacol. 2023;949:175586. https:\/\/doi.org\/10.1016\/j.ejphar.2023.175586.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"219_CR64","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1006\/gyno.2000.6056","volume":"80","author":"M Hirai","year":"2001","unstructured":"Hirai M, Nakagawara A, Oosaki T, Hayashi Y, Hirono M, Yoshihara T. Expression of vascular endothelial growth factors (VEGF-A\/VEGF-1 and VEGF-C\/VEGF-2) in postmenopausal uterine endometrial carcinoma. Gynecol Oncol. 2001;80(2):181\u20138. https:\/\/doi.org\/10.1006\/gyno.2000.6056.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"219_CR65","first-page":"98","volume":"24","author":"X-L Wang","year":"2010","unstructured":"Wang X-L, Pan Z-M, Li A, Li A, Zhu M-Y. Study on the correlation of Xinjiang endometrial tumor and vascular endothelial growth factor. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2010;24(2):98\u2013100.","journal-title":"Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi"},{"issue":"5","key":"219_CR66","doi-asserted-by":"publisher","first-page":"4651","DOI":"10.1007\/s13277-014-1609-6","volume":"35","author":"SK Saarelainen","year":"2014","unstructured":"Saarelainen SK, Staff S, Peltonen N, Lehtim\u00e4ki T, Isola J, Kujala PM, et al. Endoglin, VEGF, and its receptors in predicting metastases in endometrial carcinoma. Tumor Biology. 2014;35(5):4651\u20137. https:\/\/doi.org\/10.1007\/s13277-014-1609-6.","journal-title":"Tumor Biology"},{"issue":"24","key":"219_CR67","doi-asserted-by":"publisher","first-page":"7487","DOI":"10.1158\/1078-0432.CCR-07-1017","volume":"13","author":"AA Kamat","year":"2007","unstructured":"Kamat AA, Merritt WM, Coffey D, Lin YG, Patel PR, Broaddus R, et al. Clinical and biological significance of vascular endothelial growth factor in endometrial cancer. Clin Cancer Res. 2007;13(24):7487\u201395. https:\/\/doi.org\/10.1158\/1078-0432.CCR-07-1017.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"219_CR68","first-page":"422","volume":"81","author":"B Dobrzycka","year":"2010","unstructured":"Dobrzycka B, Terlikowski SJ, Kwiatkowski M, Garbowicz M, Kinalski M, Chyczewski L. Prognostic significance of VEGF and its receptors in endometrioid endometrial cancer. Ginekol Pol. 2010;81(6):422\u20135.","journal-title":"Ginekol Pol"},{"issue":"6","key":"219_CR69","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1158\/0008-5472.CAN-05-1163","volume":"66","author":"IM Stefansson","year":"2006","unstructured":"Stefansson IM, Salvesen HB, Akslen LA. Vascular proliferation is important for clinical progress of endometrial cancer. Cancer Res. 2006;66(6):3303\u20139. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-1163.","journal-title":"Cancer Res"},{"issue":"4","key":"219_CR70","first-page":"677","volume":"51","author":"G Gu\u015fet","year":"2010","unstructured":"Gu\u015fet G, Costi S, Laz\u0103r E, Dema A, Cornianu M, Vernic C, P\u0103iu\u015fan L. Expression of vascular endothelial growth factor (VEGF) and assessment of microvascular density with CD34 as prognostic markers for endometrial carcinoma. Rom J Morphol Embryol. 2010;51(4):677\u201382.","journal-title":"Rom J Morphol Embryol"},{"issue":"7","key":"219_CR71","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1007\/s00432-020-03225-7","volume":"146","author":"K Abbink","year":"2020","unstructured":"Abbink K, Zusterzeel PLM, Geurts-Moespot A, van der Steen R, Span PN, Sweep F. Prognostic significance of VEGF and components of the plasminogen activator system in endometrial cancer. J Cancer Res Clin Oncol. 2020;146(7):1725\u201335. https:\/\/doi.org\/10.1007\/s00432-020-03225-7.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"2","key":"219_CR72","doi-asserted-by":"publisher","first-page":"155","DOI":"10.12865\/CHSJ.48.02.03","volume":"48","author":"I Droca\u015f","year":"2022","unstructured":"Droca\u015f I, Cr\u0103i\u0163oiu \u015e, Stepan AE, Simionescu CE, Marinescu D. VEGF immunoexpression in endometrioid endometrial carcinomas. Curr Health Sci J. 2022;48(2):155\u201361. https:\/\/doi.org\/10.12865\/CHSJ.48.02.03.","journal-title":"Curr Health Sci J"},{"issue":"9","key":"219_CR73","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1111\/j.1463-1318.2010.02357.x","volume":"13","author":"TF Hansen","year":"2011","unstructured":"Hansen TF, Jensen LH, Spindler K-LG, Lindebjerg J, Brandslund I, Jakobsen A. The relationship between serum vascular endothelial growth factor A and microsatellite instability in colorectal cancer. Colorectal Dis. 2011;13(9):984\u20138. https:\/\/doi.org\/10.1111\/j.1463-1318.2010.02357.x.","journal-title":"Colorectal Dis"},{"issue":"1","key":"219_CR74","doi-asserted-by":"publisher","first-page":"e13956","DOI":"10.1097\/MD.0000000000013956","volume":"98","author":"W Otto","year":"2019","unstructured":"Otto W, Macrae F, Sierdzi\u0144ski J, Smaga J, Kr\u00f3l M, Wili\u0144ska E, Zieniewicz K. Microsatellite instability and manifestations of angiogenesis in stage IV of sporadic colorectal carcinoma. Medicine (Baltimore). 2019;98(1):e13956. https:\/\/doi.org\/10.1097\/MD.0000000000013956.","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"219_CR75","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.surg.2005.08.006","volume":"139","author":"Y Inoue","year":"2006","unstructured":"Inoue Y, Miki C, Watanabe H, Ojima E, Kusunoki M. Genomic instability and tissue expression of angiogenic growth factors in sporadic colorectal cancer. Surgery. 2006;139(3):305\u201311. https:\/\/doi.org\/10.1016\/j.surg.2005.08.006.","journal-title":"Surgery"},{"issue":"2","key":"219_CR76","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1182\/blood-2004-07-2958","volume":"105","author":"DJ Manalo","year":"2005","unstructured":"Manalo DJ, Rowan A, Lavoie T, Natarajan L, Kelly BD, Ye SQ, et al. Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood. 2005;105(2):659\u201369. https:\/\/doi.org\/10.1182\/blood-2004-07-2958.","journal-title":"Blood"},{"issue":"46","key":"219_CR77","doi-asserted-by":"publisher","first-page":"30336","DOI":"10.1074\/jbc.273.46.30336","volume":"273","author":"HP Gerber","year":"1998","unstructured":"Gerber HP, McMurtrey A, Kowalski J, Yan M, Keyt BA, Dixit V, Ferrara N. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3\u2019-kinase\/Akt signal transduction pathway. Requirement for Flk-1\/KDR activation. J Biol Chem. 1998;273(46):30336\u201343. https:\/\/doi.org\/10.1074\/jbc.273.46.30336.","journal-title":"J Biol Chem."},{"issue":"1","key":"219_CR78","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1158\/0008-5472.CAN-12-2064","volume":"73","author":"C Daly","year":"2013","unstructured":"Daly C, Eichten A, Castanaro C, Pasnikowski E, Adler A, Lalani AS, et al. Angiopoietin-2 functions as a Tie2 agonist in tumor models, where it limits the effects of VEGF inhibition. Cancer Res. 2013;73(1):108\u201318. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-2064.","journal-title":"Cancer Res"},{"issue":"2","key":"219_CR79","first-page":"129","volume":"27","author":"M Saito","year":"2006","unstructured":"Saito M, Watanabe J, Fujisawa T, Kamata Y, Nishimura Y, Arai T, et al. Angiopoietin-1, 2 and Tie2 expressions in endometrial adenocarcinoma\u2013the Ang2 dominant balance up-regulates tumor angiogenesis in the presence of VEGF. Eur J Gynaecol Oncol. 2006;27(2):129\u201334.","journal-title":"Eur J Gynaecol Oncol"},{"issue":"8","key":"219_CR80","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1016\/j.ajpath.2014.05.006","volume":"184","author":"MK Brunckhorst","year":"2014","unstructured":"Brunckhorst MK, Xu Y, Lu R, Yu Q. Angiopoietins promote ovarian cancer progression by establishing a procancer microenvironment. Am J Pathol. 2014;184(8):2285\u201396. https:\/\/doi.org\/10.1016\/j.ajpath.2014.05.006.","journal-title":"Am J Pathol"},{"issue":"3","key":"219_CR81","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.trsl.2013.11.008","volume":"163","author":"N Luo","year":"2014","unstructured":"Luo N, Guan Q, Zheng L, Qu X, Dai H, Cheng Z. Estrogen-mediated activation of fibroblasts and its effects on the fibroid cell proliferation. Transl Res. 2014;163(3):232\u201341. https:\/\/doi.org\/10.1016\/j.trsl.2013.11.008.","journal-title":"Transl Res"},{"issue":"1","key":"219_CR82","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.fertnstert.2005.01.103","volume":"84","author":"D Denschlag","year":"2005","unstructured":"Denschlag D, Bettendorf H, Watermann D, Keck C, Tempfer C, Pietrowski D. Polymorphism of the p53 tumor suppressor gene is associated with susceptibility to uterine leiomyoma. Fertil Steril. 2005;84(1):162\u20136. https:\/\/doi.org\/10.1016\/j.fertnstert.2005.01.103.","journal-title":"Fertil Steril"},{"issue":"3","key":"219_CR83","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.jmig.2020.10.012","volume":"28","author":"M Loring","year":"2021","unstructured":"Loring M, Chen TY, Isaacson KB. A systematic review of adenomyosis: it is time to reassess what we thought we knew about the disease. J Minim Invasive Gynecol. 2021;28(3):644\u201355. https:\/\/doi.org\/10.1016\/j.jmig.2020.10.012.","journal-title":"J Minim Invasive Gynecol"},{"issue":"9447","key":"219_CR84","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0140-6736(04)17403-5","volume":"364","author":"LC Giudice","year":"2004","unstructured":"Giudice LC, Kao LC. Endometriosis. Lancet. 2004;364(9447):1789\u201399. https:\/\/doi.org\/10.1016\/S0140-6736(04)17403-5.","journal-title":"Lancet"},{"issue":"1","key":"219_CR85","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1067\/mob.2003.99","volume":"188","author":"DD Baird","year":"2003","unstructured":"Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188(1):100\u20137. https:\/\/doi.org\/10.1067\/mob.2003.99.","journal-title":"Am J Obstet Gynecol"},{"issue":"W1","key":"219_CR86","doi-asserted-by":"publisher","first-page":"W566","DOI":"10.1093\/nar\/gkv468","volume":"43","author":"T Metsalu","year":"2015","unstructured":"Metsalu T, Vilo J. ClustVis: a web tool for visualizing clustering of multivariate data using principal component analysis and heatmap. Nucleic Acids Res. 2015;43(W1):W566\u201370. https:\/\/doi.org\/10.1093\/nar\/gkv468.","journal-title":"Nucleic Acids Res"},{"key":"219_CR87","doi-asserted-by":"publisher","unstructured":"Pang Z, Lu Y, Zhou G, Hui F, Xu L, Viau C, et al. MetaboAnalyst 6.0: towards a unified platform for metabolomics data processing, analysis and interpretation. Nucleic Acids Res. 2024;52:W398\u2013406.\u00a0https:\/\/doi.org\/10.1093\/nar\/gkae253.","DOI":"10.1093\/nar\/gkae253"}],"container-title":["Molecular Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-024-00219-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43556-024-00219-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-024-00219-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T01:02:43Z","timestamp":1731027763000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43556-024-00219-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,8]]},"references-count":87,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["219"],"URL":"https:\/\/doi.org\/10.1186\/s43556-024-00219-6","relation":{},"ISSN":["2662-8651"],"issn-type":[{"value":"2662-8651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,8]]},"assertion":[{"value":"30 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board at the University of Arizona (IRB no. 1708726047) and performed in accordance with the Declaration of Helsinki and federal guidelines. All participants provided written informed consent to participate in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MMH-K is on the scientific advisory board for Freya Biosciences. DMC reports personal fees from Astra Zeneca, Eisai, GSK, Immunogen, and Merck. None of this work related to, was shared with, or was licensed to these companies or any other commercial entity. All other authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"55"}}